Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    16196117 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti
Condition: Anterior Uveitis
Intervention: Drug: Sirolimus
2 Unknown  Myfortic for the Treatment of Non-infectious Intermediate Uveitis
Condition: Non-infectious Intermediate Uveitis
Interventions: Drug: Myfortic;   Drug: Decortin
3 Not yet recruiting PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Conditions: Macular Edema;   Uveitis
Interventions: Drug: Periocular triamcinolone 40 mg;   Drug: Intravitreal triamcinolone 4 mg;   Drug: Dexamethasone intravitreal implant

Indicates status has not been verified in more than two years